Serina Therapeutics (SER) EPS (Basic) (2018 - 2026)
Serina Therapeutics' (SER) quarterly EPS (Basic) came in at -$0.55 in Q2 2026, up 16.93% year-over-year from -$0.47 in Q2 2025, and up 13.27% quarter-over-quarter from -$0.63 in Q4 2025.
Analysis
Serina Therapeutics (SER) EPS (Basic) (2018 - 2026) Analysis & Trends
Serina Therapeutics has disclosed EPS (Basic) across 9 years of filings, most recently posting -$0.55 for Q2 2026.
- In Q2 2026, EPS (Basic) rose 16.93% year-over-year to -$0.55; the TTM figure through Jun 2026 stood at -$1.73 (up 25.9% YoY), while the FY2025 annual figure was -$1.91, down 25.99% from the prior year.
- EPS (Basic) came in at -$0.55 for Q2 2026 at Serina Therapeutics, up from -$0.63 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.06 in Q4 2023 to a low of -$0.9 in Q1 2024.
- Average EPS (Basic) over 5 years is -$0.36, with a median of -$0.49 recorded in 2024.
- Year-over-year, EPS (Basic) soared 182.82% in 2023 and slumped 3153.87% in 2024.
- Over 5 years, EPS (Basic) stood at -$0.07 in 2022, then soared by 182.82% to $0.06 in 2023, then slumped by 1355.55% to -$0.76 in 2024, then increased by 16.9% to -$0.63 in 2025, then grew by 13.27% to -$0.55 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$0.55 in Q2 2026, -$0.63 in Q4 2025, and -$0.62 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 4.40 |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 4.34 |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 12.62 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 7.70 |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 1.23 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -0.40 |
| 10 | Serina Therapeutics | 40.47 Mn | 17.45 Mn | - | -0.55 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.55 |
| Dec 31, 2025 | -0.63 |
| Sep 30, 2025 | -0.62 |
| Jun 30, 2025 | -0.66 |
| Mar 31, 2025 | -0.60 |
| Dec 31, 2024 | -0.76 |
| Sep 30, 2024 | -0.60 |
| Jun 30, 2024 | -0.49 |
| Mar 31, 2024 | -0.90 |
| Dec 31, 2023 | 0.06 |
| Sep 30, 2023 | -0.04 |
| Jun 30, 2023 | -0.03 |
| Mar 31, 2023 | -0.03 |
| Dec 31, 2022 | -0.07 |
| Sep 30, 2022 | -0.06 |
| Jun 30, 2022 | -0.07 |
| Mar 31, 2022 | -0.07 |
| Dec 31, 2021 | -0.06 |
| Sep 30, 2021 | -0.05 |
| Jun 30, 2021 | -0.07 |